A former CEO of a drug compounding company has been sentenced to prison after being accused of defrauding the FDA and distributing adulterated drugs.
Paul J. Elmer, 68, the former president and owner of Pharmakon Pharmacueticals Inc. has been sentenced to 33 months in prison. He was also ordered to pay a $25,000 fine and serve one year of supervised release after serving his prison sentence.
At trial, evidence showed that Pharmakon routinely shipped compounded drugs to hospitals without having received laboratory results that verified that the drugs were their purported strengths. They also did not report the over or under potent drugs to the FDA or recall them to ensure the public’s safety.
In February of 2016, Pharmakon distributed 2,460 percent super-potent morphine sulfate, an opioid pain medication, to hospitals in Indianapolis and Chicago. These were given to infants, with nurses not knowing they were over strength, several of whom then suffered narcotic overdoses.